S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Intuitive Surgical Leads the Robotic Surgery Movement
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Intuitive Surgical Leads the Robotic Surgery Movement
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Intuitive Surgical Leads the Robotic Surgery Movement
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Stock market today: World shares shrug off Wall St blues as investors eye corporate earnings
Intuitive Surgical Leads the Robotic Surgery Movement
NASDAQ:ATNF

180 Life Sciences (ATNF) Stock Price, News & Analysis

$1.82
-0.01 (-0.54%)
(As of 04/19/2024 08:50 PM ET)
Today's Range
$1.80
$1.94
50-Day Range
$1.48
$4.15
52-Week Range
$1.33
$27.93
Volume
19,800 shs
Average Volume
110,659 shs
Market Capitalization
$1.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ATNF stock logo

About 180 Life Sciences Stock (NASDAQ:ATNF)

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

ATNF Stock Price History

ATNF Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
180 Life Sciences Announces 1-For 19 Reverse Stock Split - Quick Facts
180 Life Sciences Corp.
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
180 Life Sciences Corp. Common Stock (ATNF)
Why Is 180 Life Sciences (ATNF) Stock Up 30% Today?
See More Headlines
Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/21/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATNF
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
$-19,930,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.24) per share

Miscellaneous

Free Float
818,000
Market Cap
$1.55 million
Optionable
No Data
Beta
0.44
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Lawrence Steinman BA (Age 76)
    M.D., Ph.D., Co-Founder & Executive Chairman
    Comp: $168.75k
  • Dr. James N. Woody M.D. (Age 82)
    Ph.D., CEO & Director
    Comp: $617.77k
  • Mr. Ozan Pamir C.F.A. (Age 32)
    CFO & Secretary
    Comp: $410.24k
  • Dr. Jonathan B. Rothbard Ph.D. (Age 71)
    Chief Scientific Officer
    Comp: $260.34k
  • Prof. Jagdeep Nanchahal
    Co-Founder & Chairman of Clinical Advisory Board
  • Mr. Jason Assad
    Director of IR

ATNF Stock Analysis - Frequently Asked Questions

How have ATNF shares performed in 2024?

180 Life Sciences' stock was trading at $4.0565 at the start of the year. Since then, ATNF stock has decreased by 55.1% and is now trading at $1.8201.
View the best growth stocks for 2024 here
.

Are investors shorting 180 Life Sciences?

180 Life Sciences saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 42,400 shares, a decrease of 31.4% from the March 15th total of 61,800 shares. Based on an average trading volume of 96,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 8.4% of the company's shares are sold short.
View 180 Life Sciences' Short Interest
.

When is 180 Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our ATNF earnings forecast
.

When did 180 Life Sciences' stock split?

180 Life Sciences's stock reverse split on Wednesday, February 28th 2024. The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of 180 Life Sciences?

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATNF) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners